Oncologie

Detection of HER2-positive circulating tumor cells and circulating endothelial cells in an ancillary study of the BEVERLY2 multicenter phase II trial of neoadjuvant chemotherapy combined with Trastuzumab and §Bevacizumab in HER2-overexpressing inflammatory breast cancer

AACR 2010 – Poster #2233

J.Y. Pierga, C. Mat-hiot, F.C. Bidard, T. Petit, T. Delozier, J.M. Ferrero, M. Campone, J. Gligorov, F. Lerebours, H. Roché, L. Bobadilla, P. Viens

Vous souhaitez échanger
avec nos équipes

Contactez-nous

D’autres articles qui pourraient
vous intéresser

Risk Factors TFR CP-CML
Success stories - Oncologie - Facultatif

Identification of Individual Risk Factors for Treatment Free Remission (TFR) Failure in Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients

Long-Term TKI Treatment Patterns
Success stories - Oncologie - Facultatif

Tyrosine Kinase Inhibitor (TKI) Treatment Patterns in 5,261 Chronic Phase (CP) Chronic Myeloid Leukemia (CML) Patients in “Real-Life”

Use of Digital Health Technology to Enable Drug Development
Oncologie

Use of Digital Health Technology to Enable Drug Development